Patents
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/2007
10/25/2007WO2007118967A1 Use of cholest-4-in-3-in-one derivatives to obtain a cytoprotective medicine
10/25/2007WO2007118964A1 Substituted n-(phenethyl)benzamide derivatives, preparation and uses thereof
10/25/2007WO2007118949A1 Method of preparing a pulverulent composition and product as obtained
10/25/2007WO2007118947A1 Novel amphiphilic derivatives of alpha-c-phenyl-n-tert-butylnitrone
10/25/2007WO2007118903A1 Trisubstituted 1,2,4-triazoles
10/25/2007WO2007118900A1 Heterocyclic compounds suitable for treating disorders that respond to modulation of the serotonin 5ht6 receptor
10/25/2007WO2007118899A1 Heterocyclic arylsulphones suitable for treating disorders that respond to modulation of the serotonin 5ht6 receptor
10/25/2007WO2007118873A2 Polymorphs of atorvastatin sodium and magnesium salts
10/25/2007WO2007118859A1 Aryloxyethylamine compounds suitable for treating disorders that respond to modulation of the dopamine d3 receptor
10/25/2007WO2007118854A1 Benzenesulfonamide compounds and the use thereof
10/25/2007WO2007118853A1 Benzenesulfonamide compounds and their use as blockers of calcium channels
10/25/2007WO2007118852A1 Aryl and heteroaryl sulphonamides as growth hormone secretagogue receptor agonists
10/25/2007WO2007118844A1 Substituted pyrazolopyrimidines, process for their preparation and their use for controlling harmful fungi and compositions comprising them
10/25/2007WO2007118832A2 Amino derivatives of androstanes and androstenes as medicaments for cardiovascular disorders
10/25/2007WO2007118830A1 Azaheterocyclyl derivatives of androstanes and androstenes as medicaments for cardiovascular disorders
10/25/2007WO2007118819A2 Novel crystalline compounds
10/25/2007WO2007118802A1 Aerosol suspension formulations comprising tg 227 ea or tg 134 a as propellants
10/25/2007WO2007118793A1 Dihydrothienopyrimidine for treating inflammatory disorders
10/25/2007WO2007118717A2 METHOD FOR PREPARING 4-[17β-METHOXY-17α-METHOXYMETHYL-3-OXOESTRA-4,9-DIEN-11β-YL]BENZALDEHYDE (E)-OXIME (ASOPRISNIL)
10/25/2007WO2007118711A1 17α-SUBSTITUTED 4-(3-OXOESTRA-4,9-DIEN-11β-YL)-BENZOIC ACID, ITS DERIVATIVES AND PROCESS FOR ITS PRODUCTION
10/25/2007WO2007118651A1 Synthesis of acylaminoalkenylene amides useful as substance p antagonists
10/25/2007WO2007118602A1 Compounds for treating pulmonary hypertension
10/25/2007WO2007118430A1 A functional composite material with good curative effect and preparation, uses thereof
10/25/2007WO2007118335A1 Hepoxilin analog enantiomers
10/25/2007WO2007118329A1 Methods and agents for treating tuberculosis
10/25/2007WO2007118325A1 Enhancement of memory and/or cognition using substituted butyrophenone compounds
10/25/2007WO2007118323A1 Isoxazole derivatives as calcium channel blockers
10/25/2007WO2007118318A1 USE OF IMIDAZO[2,1-b)]-1,3,4-THIADIAZOLE-2-SULFONAMIDE COMPOUNDS TO TREAT NEUROPATHIC PAIN
10/25/2007WO2007118314A1 1,5 and 3,6- substituted indole compounds having nos inhibitory activity
10/25/2007WO2007118276A1 Method of treatment of age-related macular degeneration(amd)
10/25/2007WO2007106467A3 Polymorphs of n-(4-chloro-3-methyl-5-isoxazolyl)2-[2-methyl-4,5-(methylenedioxy) phenylacetyl]thiophene-3-sulfonamide, sodium salt
10/25/2007WO2007103160A3 Stearidonic acid for improving cardiovascular health
10/25/2007WO2007101864A3 Compounds that modulate ppar activity, their preparation and use
10/25/2007WO2007101551A3 Phospholipid complexes of curcumin having improved bioavailability
10/25/2007WO2007100634A3 Immune response modifier conjugates
10/25/2007WO2007099216A3 β-CRYSTALLINE FORM OF PERINDOPRIL ARGININE SALT, METHOD FOR MAKING SAME, AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME
10/25/2007WO2007098591A3 Topical nail formulation
10/25/2007WO2007098352A3 Substituted pyridineamide compounds useful as soluble epoxide hydrolase inhibitors
10/25/2007WO2007098270A3 Co-crystals comprising vx-950 and pharmaceutical compositions comprising the same
10/25/2007WO2007097981A3 Alpha carbolines and uses thereof
10/25/2007WO2007097839A3 Ansamycin analogs or heat shock 90 inhibitors in combination with pdt treatin conditions of the eye
10/25/2007WO2007096902A3 Solid oral dosage forms of griseofulvin
10/25/2007WO2007095188A3 Dihydrodiazepines useful as inhibitors of protein kinases
10/25/2007WO2007093184A3 Treatment of mmp-mediated dermatological diseases with pemirolast
10/25/2007WO2007090095A3 Synthesis of carotenoid analogs or derivatives with improved antioxidant characteristics
10/25/2007WO2007089903A3 Cationic steroid microbial compositions for treating or preventing influenza infections
10/25/2007WO2007088450A3 Chromane antagonist of the h-3 receptor
10/25/2007WO2007088276A3 Sulfonamide derivatives, preparation and therapeutic application thereof
10/25/2007WO2007087066A3 1-(benzo [d] [1,3] di0x0l-5-yl) -n- (phenyl) cyclopropane- carboxamide derivatives and related compounds as modulators of atp-binding cassette transporters for the treatment of cystic fibrosis
10/25/2007WO2007085954A3 Aminophthalazine derivative compounds
10/25/2007WO2007080484A3 Flavonoids isolated from oroxylum indicum for treatment of gastrointestinal toxicity, associated symptoms and ulcers
10/25/2007WO2007077508A3 Derivatives of beta-amino acid as dipeptidyl peptidase-iv inhibitors
10/25/2007WO2007076070A3 Modulators of muscarinic receptors
10/25/2007WO2007073518A3 Compounds and methods for thiol-containing compound efflux and cancer treatment
10/25/2007WO2007072153A3 Carbonylamino pyrrolopyrazoles, potent kinase inhibitors
10/25/2007WO2007070393A3 Mglur1 anatgonists as therapeutic agents
10/25/2007WO2007067593A3 Self-emulsifyng formulations of cetp inhibitors
10/25/2007WO2007066784A3 Diarylether derivatives as antitumor agents
10/25/2007WO2007064912A3 Mometasone compositions and methods of making and using the same
10/25/2007WO2007064883A3 Substituted 4-amino-pyrrolotriazine derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis
10/25/2007WO2007064871A3 Diagnostic and treatment regimen for achieving body water homeostasis
10/25/2007WO2007059422A3 Pharmaceutical formulations containing 5-cyclopropyl-2(4-fluorophenyl)-6-[(2-hydroxyethyl)(methylsulfonyl) amino]-n-methyl-1-benzofuran-3-carboxamide and method of making same
10/25/2007WO2007056556A3 Polyethylene glycol conjugates of pyridinium and thiazolium compounds and methods of using the same
10/25/2007WO2007056208A3 N-arylalkyl-thienopyrimidin-4-amines and analogs as activators of caspases and inducers of apoptosis and the use thereof
10/25/2007WO2007053747A3 Modulating endoplasmic reticulum stress in the treatment of tuberous sclerosis
10/25/2007WO2007052169A3 Hypophosphorous acid derivatives and their therapeutical applications
10/25/2007WO2007050892A3 Camptothecin derivatives and improved synthetic methods
10/25/2007WO2007050599A3 Ginkgolides in the treatment and prevention of ovarian cancer
10/25/2007WO2007049043A3 Tnf alpha ngf molecular switch for determining cell fate
10/25/2007WO2007041368A3 Dpp iv inhibitor for use in the treatment of autoimmune diseases and graft rejection
10/25/2007WO2007041112A3 Dihydro-[1h]-quinolin-2-one derivatives as rxr agonists for the treatment of dyslipidemia, hypercholesterolemia and diabetes
10/25/2007WO2007039909A3 Compositions and methods for treatment of renal failure
10/25/2007WO2007038788A3 Small interfering rnas as non-specific drugs
10/25/2007WO2007038630A3 N-benzyl substituted pyridyl porphyrin compounds and methods of use thereof
10/25/2007WO2007038425A3 Anti-viral compouinds
10/25/2007WO2007035942A3 Transdermal risperidone delivery system
10/25/2007WO2007035879A3 Combination s-nitrosothiol-based pharmaceutical products for restoring normal breathing rhythm
10/25/2007WO2007035709A3 Novel crystal forms of irinotecan hydrochloride
10/25/2007WO2007033058A3 Compositions and methods for regulating rna translation via cd154 ca-dinucleotide repeat
10/25/2007WO2007032777A3 Compositions and methods of administering rapamycin analogs using medical devices for long-term efficacy
10/25/2007WO2007027987A3 Method of treating parkinson's disease with diarylmethylpiperazine compounds exhibiting delta receptor agonist activity
10/25/2007WO2007022434A3 Anti-inflammatory activity of phenethylisothiocyanate (peitc) and the barbarea verna seed preparation containing this compound
10/25/2007WO2007022377A3 Conformable solvent-based bandage and coating material
10/25/2007WO2007020193A3 Antiviral phosphoramidates of 4 ' -substituted pronucleotides
10/25/2007WO2007017890A3 Process for preparation of pantoprazole sodium sesquihydrate and product prepared therby
10/25/2007WO2007011940A3 Sustained release of antiinfectives
10/25/2007WO2007005779A3 Antiviral agents
10/25/2007WO2007005737A3 Amine oxidase inhibitors
10/25/2007WO2007002881A3 Compositions and methods of use of derivatized flavanols
10/25/2007WO2007002285A3 Methods for treating neurological and psychiatric conditions
10/25/2007WO2006137839A3 Combination therapy for treating cyclooxygenase-2 mediated diseases or conditions in patients at risk of thrombotic cardiovascular events
10/25/2007WO2006135604A3 Inhibitors of checkpoint kinases
10/25/2007WO2006121831A3 Hiv integrase inhibitors
10/25/2007WO2006119355A3 Mammalian hypothalamic nutrient modulation of glucose metabolism
10/25/2007WO2006103342A9 Indanyl-piperazine derivatives, method for preparing same and pharmaceutical compositions containing same
10/25/2007WO2006099275A3 Method of treating actinic keratosis
10/25/2007WO2006096806A3 Treatment with statin and omega-3 fatty acids and a combination product thereof
10/25/2007WO2006086773A3 Polyamine analogs as modulators of cell migration and cell motility
10/25/2007WO2006069064A3 Conserved hbv and hcv sequences useful for gene silencing
10/25/2007WO2006033844A9 4-arylspirocycloalkyl-2-aminopyrimidine carboxamide kcnq potassium channel modulators